{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:24:30Z","timestamp":1787037870152,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-M\u00fcllerian hormone (AMH) is widely used as a marker of ovarian reserve. However, its reliability in functional hypothalamic amenorrhea (FHA) remains debated. FHA is characterized by reduced gonadotropin secretion and impaired folliculogenesis, which may influence AMH expression and lead to an underestimation of reproductive potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a case\u2013control study including women diagnosed with FHA and age-matched healthy controls. FHA patients were stratified according to the presence or absence of polycystic ovarian morphology (PCOM). Serum gonadotropins, estradiol, androgens, and AMH were measured and compared between groups. Correlation analyses were performed to explore associations among hormonal parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, AMH concentrations in FHA patients were comparable to those of controls. However, stratification revealed that FHA without PCOM was associated with significantly reduced AMH, whereas FHA with PCOM displayed increased values. FHA patients also showed reduced gonadotropins, estradiol, and androgens compared with controls. In the non-PCOM FHA subgroup, AMH correlated positively with androgens and negatively with estradiol. These findings suggest that suppression of gonadotropins and consequent androgen deficiency may contribute to reduced AMH levels in FHA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This pilot study indicates that low AMH in FHA may reflect hypothalamic suppression of gonadotropins rather than true ovarian reserve potentially leading to misinterpretation in fertility counseling. These observations should be interpreted with caution given the small sample size, but they support the hypothesis that AMH levels might recover with restoration of hypothalamic\u2013pituitary activity and menstrual cycles. Larger, longitudinal studies are warranted to confirm the reversibility of AMH and clarify its prognostic value in FHA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p>Proposed mechanism linking hypothalamic suppression to reduced AMH levels in functional hypothalamic amenorrhea (FHA). Reduced GnRH pulsatility leads to decreased LH secretion and consequent reduction in ovarian androgen production. The resulting hypoandrogenic environment impairs granulosa cell function and attenuates AMH production, reflecting a functional and potentially reversible suppression rather than an irreversible depletion of ovarian reserve.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-02878-4","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:52:43Z","timestamp":1778061163000},"page":"1919-1930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional hypothalamic amenorrhea and anti-M\u00fcllerian hormone: insights for fertility assessment"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-6877","authenticated-orcid":false,"given":"Giovanna","family":"Notaristefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tropea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya","family":"Samasiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Ranalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Asia","family":"Policriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Diterlizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tullio","family":"Ghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lanzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Apa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"2878_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2004.09.008","author":"JA Visser","year":"2005","unstructured":"Visser JA, Themmen APN (2005) Anti-M\u00fcllerian hormone and folliculogenesis. Mol Cell Endocrinol. https:\/\/doi.org\/10.1016\/j.mce.2004.09.008","journal-title":"Mol Cell Endocrinol"},{"key":"2878_CR2","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"ALL Durlinger","year":"2001","unstructured":"Durlinger ALL, Gruijters MJG, Kramer P et al (2001) Anti-Mu\u0308llerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891\u20134899. https:\/\/doi.org\/10.1210\/endo.142.11.8486","journal-title":"Endocrinology"},{"key":"2878_CR3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa513","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA (2020) Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgaa513","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.10.018","volume":"111","author":"N Sermondade","year":"2019","unstructured":"Sermondade N, Sonigo C, Sifer C et al (2019) Serum Anti-M\u00fcllerian hormone is associated with the number of oocytes matured in\u00a0vitro and with primordial follicle density in candidates for fertility preservation. Fertil Steril 111:. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.10.018","journal-title":"Fertil Steril"},{"key":"2878_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino I, Casoni F, Liu X et al (2016) Novel role for Anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun 7:10055. https:\/\/doi.org\/10.1038\/ncomms10055","journal-title":"Nat Commun"},{"key":"2878_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0368","author":"ND Tran","year":"2011","unstructured":"Tran ND, Cedars MI, Rosen MP (2011) The Role of Anti-M\u00fcllerian Hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2011-0368","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00686","volume":"9","author":"L Melado","year":"2018","unstructured":"Melado L, Lawrenz B, Sibal J et al (2018) Anti-M\u00fcllerian hormone during natural cycle presents significant intra and intercycle variations when measured with fully automated assay. Front Endocrinol (Laus) 9:. https:\/\/doi.org\/10.3389\/fendo.2018.00686","journal-title":"Front Endocrinol (Laus)"},{"key":"2878_CR8","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.fertnstert.2009.07.1676","volume":"93","author":"SM Nelson","year":"2010","unstructured":"Nelson SM, Stewart F, Fleming R, Freeman DJ (2010) Longitudinal assessment of Anti-M\u00fcllerian hormone during pregnancy\u2014relationship with maternal adiposity, insulin, and adiponectin. Fertil Steril 93:1356\u20131358. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.07.1676","journal-title":"Fertil Steril"},{"key":"2878_CR9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","volume":"99","author":"S Kallio","year":"2013","unstructured":"Kallio S, Puurunen J, Ruokonen A et al (2013) Anti-M\u00fcllerian hormone levels decrease in women using combined contraception independently of administration route. Fertil Steril 99:1305\u20131310. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.11.034","journal-title":"Fertil Steril"},{"key":"2878_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ando.2010.02.024","volume":"71","author":"H Bry-Gauillard","year":"2010","unstructured":"Bry-Gauillard H, Trabado S, Bouligand J et al (2010) Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics. Ann Endocrinol (Paris) 71:158\u2013162. https:\/\/doi.org\/10.1016\/j.ando.2010.02.024","journal-title":"Ann Endocrinol (Paris)"},{"key":"2878_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4250","author":"B Deubzer","year":"2014","unstructured":"Deubzer B, Weber K, Lawrenz B et al (2014) Anti-Mullerian hormone deficiency in girls with congenital multiple pituitary hormone deficiency. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/jc.2013-4250","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2265.1999.00649.x","volume":"50","author":"B Couzinet","year":"1999","unstructured":"Couzinet B, Young J, Brailly S et al (1999) Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 50:229\u2013235","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2878_CR13","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1210\/jc.2017-00131","volume":"102","author":"CM Gordon","year":"2017","unstructured":"Gordon CM, Ackerman KE, Berga SL et al (2017) Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 102:1413\u20131439. https:\/\/doi.org\/10.1210\/jc.2017-00131","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.112","author":"U Boehm","year":"2015","unstructured":"Boehm U, Bouloux PM, Dattani MT et al (2015) European consensus statement on congenital hypogonadotropic hypogonadism\u2014pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/nrendo.2015.112","journal-title":"Nat Rev Endocrinol"},{"key":"2878_CR15","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.fertnstert.2005.10.057","volume":"85","author":"A La Marca","year":"2006","unstructured":"La Marca A, Pati M, Orvieto R et al (2006) Serum anti-M\u00fcllerian hormone levels in women with secondary amenorrhea. Fertil Steril 85:1547\u20131549. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.10.057","journal-title":"Fertil Steril"},{"key":"2878_CR16","doi-asserted-by":"publisher","first-page":"e2008","DOI":"10.1210\/clinem\/dgaa116","volume":"105","author":"A Alemyar","year":"2020","unstructured":"Alemyar A, van der Kooi ALLF, Laven JSE (2020) Anti-M\u00fcllerian hormone and ovarian morphology in women with hypothalamic hypogonadism. J Clin Endocrinol Metab 105:e2008\u2013e2014. https:\/\/doi.org\/10.1210\/clinem\/dgaa116","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14402","author":"M Phylactou","year":"2021","unstructured":"Phylactou M, Clarke SA, Patel B et al (2021) Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14402","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2878_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/humrep\/deab024","volume":"36","author":"S Makolle","year":"2021","unstructured":"Makolle S, Catteau-Jonard S, Robin G, Dewailly D (2021) Revisiting the serum level of anti-M\u00fcllerian hormone in patients with functional hypothalamic anovulation. Hum Reprod 36:1043\u20131051. https:\/\/doi.org\/10.1093\/humrep\/deab024","journal-title":"Hum Reprod"},{"key":"2878_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1395842","author":"E Carmina","year":"2018","unstructured":"Carmina E, Fruzzetti F, Lobo RA (2018) Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function. Gynecol Endocrinol. https:\/\/doi.org\/10.1080\/09513590.2017.1395842","journal-title":"Gynecol Endocrinol"},{"key":"2878_CR20","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.1210\/jc.2012-1836","volume":"97","author":"G Robin","year":"2012","unstructured":"Robin G, Gallo C, Catteau-Jonard S et al (2012) Polycystic ovary-like abnormalities (PCO-L) in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 97:4236\u20134243. https:\/\/doi.org\/10.1210\/jc.2012-1836","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"2878_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"2878_CR23","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.18.03490-0","author":"M Imterat","year":"2019","unstructured":"Imterat M, Agarwal A, Esteves SC et al (2019) Impact of body mass index on female fertility and ART outcomes. Panminerva Med. https:\/\/doi.org\/10.23736\/S0031-0808.18.03490-0","journal-title":"Panminerva Med"},{"key":"2878_CR24","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","volume":"85","author":"R Pasquali","year":"2006","unstructured":"Pasquali R (2006) Obesity and androgens: facts and perspectives. Fertil Steril 85:1319\u20131340. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.10.054","journal-title":"Fertil Steril"},{"key":"2878_CR25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E et al (2022) Polycystic ovary syndrome. Lancet Diabetes Endocrinol 10:668\u2013680. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2878_CR26","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1210\/en.2019-00487","volume":"160","author":"NM Lainez","year":"2019","unstructured":"Lainez NM, Coss D (2019) Obesity, neuroinflammation, and reproductive function. Endocrinol 160:2719\u20132736. https:\/\/doi.org\/10.1210\/en.2019-00487","journal-title":"Endocrinol"},{"key":"2878_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","volume":"25","author":"D Unuane","year":"2011","unstructured":"Unuane D, Tournaye H, Velkeniers B, Poppe K (2011) Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab 25:861\u2013873. https:\/\/doi.org\/10.1016\/j.beem.2011.08.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2878_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cen.14399","volume":"95","author":"AE Morrison","year":"2021","unstructured":"Morrison AE, Fleming S, Levy MJ (2021) A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to psychological stress, disordered eating, excessive exercise or a combination of these factors. Clin Endocrinol (Oxf) 95:229\u2013238. https:\/\/doi.org\/10.1111\/cen.14399","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2878_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1210\/jc.2016-3799","volume":"102","author":"H Bry-Gauillard","year":"2017","unstructured":"Bry-Gauillard H, Larrat-Ledoux F, Levaillant JM et al (2017) Anti-M\u00fcllerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism\/Kallmann syndrome: effects of recombinant human FSH. J Clin Endocrinol Metab 102:1102\u20131111. https:\/\/doi.org\/10.1210\/jc.2016-3799","journal-title":"J Clin Endocrinol Metab"},{"key":"2878_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/humupd\/dmw027","volume":"22","author":"D Dewailly","year":"2016","unstructured":"Dewailly D, Robin G, Peigne M et al (2016) Interactions between androgens, FSH, anti-M\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update 22:709\u2013724. https:\/\/doi.org\/10.1093\/humupd\/dmw027","journal-title":"Hum Reprod Update"},{"key":"2878_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/humrep\/deh560","volume":"20","author":"S Jonard","year":"2005","unstructured":"Jonard S, Pigny P, Jacquesson L et al (2005) The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea. Hum Reprod 20:101\u2013107. https:\/\/doi.org\/10.1093\/humrep\/deh560","journal-title":"Hum Reprod"},{"key":"2878_CR32","doi-asserted-by":"publisher","first-page":"E1649","DOI":"10.1210\/jc.2011-3133","volume":"97","author":"M Grynberg","year":"2012","unstructured":"Grynberg M, Pierre A, Rey R et al (2012) Differential regulation of ovarian anti-M\u00fcllerian hormone (AMH) by estradiol through \u03b1- and \u03b2-estrogen receptors. J Clin Endocrinol Metab 97:E1649\u2013E1657. https:\/\/doi.org\/10.1210\/jc.2011-3133","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02878-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02878-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02878-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:29:40Z","timestamp":1787034580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02878-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2878"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02878-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki (2013 revision) ad was approved by the Ethics Committee of Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Rome, Italy) (Prot. N. 0019027\/23, June 16, 2023; ID 5321). All participants provided written informed consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}